Atlas Trials

Study of Bemnifosbuvir in Subjects With Normal and Impaired Hepatic Function

Clinical trial NCT05724693 · COMPLETED

Trial details

NCT number
NCT05724693
Sponsor
Atea Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy VolunteerHepatic Impairment
Start date
2023-01-30
Primary completion
2024-04-23
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.